48 filings
8-K
TFFP
Tff Pharmaceuticals Inc
28 Mar 24
TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
4:05pm
8-K
TFFP
Tff Pharmaceuticals Inc
27 Mar 24
Regulation FD Disclosure
4:01pm
8-K
TFFP
Tff Pharmaceuticals Inc
22 Mar 24
TFF Pharmaceuticals Announces $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
4:25pm
8-K
TFFP
Tff Pharmaceuticals Inc
19 Dec 23
TFF Pharmaceuticals Announces Reverse Stock Split
6:07am
8-K
TFFP
Tff Pharmaceuticals Inc
15 Dec 23
TFF Pharmaceuticals Appoints Thomas B. King to Board of Directors
4:06pm
8-K
smtki
8 Dec 23
Departure of Directors or Certain Officers
4:10pm
8-K
gzgfnj69hc 69
4 Dec 23
TFF Pharmaceuticals Appoints Catherine Lee, J.D. to Board of Directors
5:26pm
8-K
57ry9ed6
22 Nov 23
Amendments to Articles of Incorporation or Bylaws
5:14pm
8-K
lvwukobpci e9hv63mi
14 Nov 23
TFF Pharmaceuticals Reports Third Quarter 2023 Financial Results
4:06pm
8-K
dz1n45
18 Sep 23
Regulation FD Disclosure
5:20pm
8-K
0e45w1 nu
18 Sep 23
Departure of Directors or Certain Officers
4:10pm
8-K
hr491
15 Aug 23
TFF Pharmaceuticals Announces Proposed Public Offering of Common Stock
6:11am
8-K
gv3c58ebgh9xsrfya4
23 Jun 23
Other Events
5:15pm
8-K
hzetcdl zjz23jk0
11 May 23
TFF Pharmaceuticals Provides Corporate Update and Reports First Quarter 2023 Financial Results
4:01pm
8-K
lu7b3008q gj
6 Apr 23
Amendments to Articles of Incorporation or Bylaws
4:05pm
8-K
hm8mxb42o8hohpf
8 Mar 23
Regulation FD Disclosure
4:05pm
8-K
jot2x tuar
7 Mar 23
TFF Pharmaceuticals Reports Fourth Quarter 2022 and Full Year 2022 Financial Results
4:17pm
8-K
hgqq7h dwko7a
16 Feb 23
2023 Corporate Update Conference Call Script
8:21pm
8-K
z82hz6 lw0ipchsqt
16 Feb 23
Regulation FD Disclosure
4:06pm
8-K
noxmt
9 Feb 23
Submission of Matters to a Vote of Security Holders
5:19pm